Official announcements
Recall
|
Medicines
|
08/04/2020
Recall due to colourless, instead of milky white emulsion
messages in brief
|
12/03/2020
NTA Vol. 2C: The "Guideline on the Packaging Information of medicinal products for human use authorised by the Community" - so called "Blue-Box Guideline für zentralen Zulassungen" can be found on the following website::…
Recall
|
Medicines
|
12/03/2020
Recall due to increased reports of ring breakage
Recall
|
Medicines
|
03/03/2020
Recall due to particles affecting batches 8234, 8235 und 8236
Recall
|
Medicines
|
26/02/2020
Recall due to reduced active ingredient content
Safety warnings
|
Medicines
|
11/02/2020
The all-clear can be given, because samples of the active substance noscapine from manufacturer and affected pharmacies have been examined in the meantime.
Incidents with extemporaneously compounded noscapine cough syrup - Usage is strongly not recommended
Safety warnings
|
Medicines
|
06/02/2020
Due to recent incidents with extemporaneously compounded products prepared noscapine cough syrup, it is recommended not to use extemporaneously compounded products noscapine cough syrup or suppositories from now on.
messages in brief
|
24/01/2020
The National Immunization Schedule 2020 is now available.
Medicines
|
16/12/2019
Marketing authorisation holders of homeopathic human medicinal products are informed that from 01.01.2020 [i.e. from the Data Lock Point: 30.09.2019] no further PSUR submissions are necessary, unless they are ordered by the BASG on a case-by-case basis.